Research Paper Volume 16, Issue 9 pp 8000—8018
A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance
Figure 5. LDHA expression at the single-cell level. (A–C) UMAP plots showing cell clusters in different cell types of multiple cancers, including LIHC, NSCLC, and PAAD. (D–F) The expression levels of LDHA in different cell types in different types of human cancers, including LIHC, NSCLC, and PAAD.